Loss of IGF2 imprinting is associated with abrogation of long-range intrachromosomal interactions in human cancer cells.
about
Cancer control and prevention by nutrition and epigenetic approachesIGF2-derived miR-483 mediated oncofunction by suppressing DLC-1 and associated with colorectal cancerIdentifying multi-locus chromatin contacts in human cells using tethered multiple 3CGenomic interaction profiles in breast cancer reveal altered chromatin architecture.CRISPR Cas9-guided chromatin immunoprecipitation identifies miR483 as an epigenetic modulator of IGF2 imprinting in tumors.Analysis of long-range chromatin interactions using Chromosome Conformation Capture.Interruption of intrachromosomal looping by CCCTC binding factor decoy proteins abrogates genomic imprinting of human insulin-like growth factor II.Estrogen-mediated epigenetic repression of the imprinted gene cyclin-dependent kinase inhibitor 1C in breast cancer cells.Genome-wide approaches for cancer gene discovery.Role of nuclear architecture in epigenetic alterations in cancer.Promoter cross-talk via a shared enhancer explains paternally biased expression of Nctc1 at the Igf2/H19/Nctc1 imprinted locus.Loss of imprinting of IGF2 and the epigenetic progenitor model of cancerThe human imprintome: regulatory mechanisms, methods of ascertainment, and roles in disease susceptibilityInsulin-like growth factor-2 (IGF2) loss of imprinting marks a field defect within human prostates containing cancer.Loss of insulin-like growth factor II imprinting is a hallmark associated with enhanced chemo/radiotherapy resistance in cancer stem cells.Gene insulation. Part II: natural strategies in vertebrates.Molecular mechanisms of genomic imprinting and clinical implications for cancer.Multi-biomarker pattern for tumor identification and prognosis.Genetic and epigenetic dysregulation of imprinted genes in the brain.Specific changes in the expression of imprinted genes in prostate cancer--implications for cancer progression and epigenetic regulation.Chromatin structure, epigenetic mechanisms and long-range interactions in the human insulin locus.Blood-based peptide, genetic, and epigenetic biomarkers for diagnosing gastrointestinal cancers.Promoter histone H3K27 methylation in the control of IGF2 imprinting in human tumor cell linesInduced DNA demethylation can reshape chromatin topology at the IGF2-H19 locus.Impairment of IGF2 gene expression in prostate cancer is triggered by epigenetic dysregulation of IGF2-DMR0 and its interaction with KLF4.Increased In Vitro Osteopotential in SHED Associated with Higher IGF2 Expression When Compared with hASCs.Extensive investigation of the IGF2/H19 imprinting control region reveals novel OCT4/SOX2 binding site defects associated with specific methylation patterns in Beckwith-Wiedemann syndrome
P2860
Q27024282-B7B1DCA3-89EF-4219-B32B-F9D4E8FD3023Q29248130-A9436C77-2911-49A2-BE3B-51AA85D19F36Q30630876-A4E743DD-3D0C-4938-AD28-3BCB097413E5Q31137734-5CD17DDC-BB1C-47B6-B926-BBA95A50F2A6Q33798311-0A15806C-12AA-4C38-9174-1F10DE66D443Q34383700-31782DCF-B727-4C68-888A-6E849357DB9AQ34918219-785C30A0-9C63-4675-B562-B3835184D7CCQ35020435-75ADEF0E-DCAA-4F29-A915-D3F5B7696B0FQ35375811-57AF00CC-32B0-4F1E-B44B-35F673033E15Q36155532-A743D313-04A1-495B-BB77-F4E095D0AC1FQ36559183-1F5CCC68-4075-404E-8348-D5E6ECBEC4CDQ36813932-2B454CB4-1989-4345-B2CD-14A648AE9691Q36931989-EF5EC660-5077-4E9F-B6D5-542BBB5DE9BFQ37301123-2B032A52-A7F6-4608-8BCA-A5AAB6E45F87Q37588289-03172AC6-C63F-4449-AD86-F3EDEB0DECE7Q37811902-975E6B02-E4C2-47CE-A7B9-560184490A22Q37831991-596BB09C-E27A-47A4-BF82-DA5A96DECD89Q37890322-0CFB2796-567E-4E37-B8C2-A4CD2BF73C08Q37961799-FE1757C3-48F3-4559-B8BA-12390E430562Q37988364-AA6A684E-2E64-466A-9C7E-A58E0BC2C810Q38038646-9C6C5881-FD21-4CC0-BF80-AD158254896AQ38089897-6330294C-E431-4D27-B8A1-F4860BE60B1FQ39107608-D1A28382-9E05-428A-86C7-12E5EC7C0C73Q39166609-5983E94F-0E4F-4D31-930C-E8F4B6AB780CQ42373538-D5D3CDEE-251C-470C-8521-58D6672BC843Q50982222-43297AC9-2990-4168-B24F-4B200D0EE0B6Q57199288-184AB0DE-6091-497F-91C8-04B77BAEE3B3
P2860
Loss of IGF2 imprinting is associated with abrogation of long-range intrachromosomal interactions in human cancer cells.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Loss of IGF2 imprinting is ass ...... actions in human cancer cells.
@ast
Loss of IGF2 imprinting is ass ...... actions in human cancer cells.
@en
type
label
Loss of IGF2 imprinting is ass ...... actions in human cancer cells.
@ast
Loss of IGF2 imprinting is ass ...... actions in human cancer cells.
@en
prefLabel
Loss of IGF2 imprinting is ass ...... actions in human cancer cells.
@ast
Loss of IGF2 imprinting is ass ...... actions in human cancer cells.
@en
P2093
P2860
P356
P1476
Loss of IGF2 imprinting is ass ...... actions in human cancer cells.
@en
P2093
An H Nguyen
Andrew R Hoffman
Thanh H Vu
P2860
P304
P356
10.1093/HMG/DDP558
P577
2009-12-16T00:00:00Z